Results 81 to 90 of about 11,211 (144)

Mitochondrial DNA Patterns Among Individuals Living With HIV-1 on Dolutegravir With Hyperglycemia. [PDF]

J Acquir Immune Defic Syndr
Buzibye A, Hoke A, Bollinger RC, Omali D, Kim SF, Jung IR, Laker E, Bagaya BS, Castelnuovo B, Manabe YC.   +9 more
europepmc   +1 more source

Urate dysregulation (hyperuricemia and gout) among people living with HIV: A protocol for a systematic review and meta-analysis. [PDF]

PLoS One
Pitua I, Otto KA, Lwembawo KD, Nantalaga KC, Nampiinga MG, Ndyomugabe M, Okema JN.   +6 more
europepmc   +1 more source

Predictors of Treatment Failure in Children With HIV Starting First-line Antiretroviral Therapy in the ODYSSEY Trial. [PDF]

Clin Infect Dis
Wyncoll J, Kamolrattana R, Archary M, Mujuru HA, Kekitiinwa AR, Violari A, Na-Rajsima S, Lugemwa A, Variava E, Cotton M, Kityo CM, Königs C, Behuhuma NO, Welch S, Saïdi Y, Marques L, Ahimbisibwe GM, Houlden L, Giaquinto C, Rojo P, Gibb DM, Puthanakit T, Turkova A, White E, Ford D, ODYSSEY Trial Team.   +25 more
europepmc   +1 more source

Uridine diphosphate glucuronosyltransferase 1A1 gene polymorphisms and treatment outcomes in HIV and MTB coinfection in sub-Saharan Africa: a scoping review protocol. [PDF]

BMJ Open
Vhanda D, Musarurwa C, Chikwati RP, Muziringa M, Dandara C, Manasa J, Chirenda J, Mavenyengwa RT.   +7 more
europepmc   +1 more source

Risk of Major Adverse Cardiovascular Events With Dolutegravir Versus Efavirenz-Based Antiretroviral Therapy: Emulated Target Trials Using Routine, De-identified Data From South Africa. [PDF]

Clin Infect Dis
Dorward J, Masombuka X, Lewis L, Pastellides C, van der Molen J, Asare K, Tlhaku K, Brown JA, Bottomley C, Jacobs D, Collie S, Garrett N.   +11 more
europepmc   +1 more source

Longitudinal Hepatic and Metabolic Trajectories Following Dolutegravir Initiation in Antiretroviral Therapy (ART)-Naïve People Living With HIV: A Prospective Cohort Study From South India. [PDF]

Cureus
Sebastian SA, Joseph J, Selvam S.
europepmc   +1 more source

Voriconazole therapeutic drug monitoring and safety in HIV-infected patients with invasive fungal disease. [PDF]

Front Pharmacol
Hu L, Su Y, Hou J, Li Y, He C.
europepmc   +1 more source

The impact of dolutegravir on the growth of HIV-exposed uninfected infants: an observational cohort study in rural Tanzania. [PDF]

EClinicalMedicine
Glanzmann S, Luoga E, Okuma J, Dotto E, Sigalla G, Franzeck FC, Nyenza E, Mnzava D, Bukuku M, Moshi L, Wilson L, Paris DH, Glass TR, Mollel GJ, Weisser M, Vanobberghen F, KIULARCO Study Group.   +16 more
europepmc   +1 more source

Synthesis and <i>in vitro</i> antiproliferative activity of dolutegravir derivatives against hepatocellular carcinoma <i>via</i> apoptosis-related mechanisms. [PDF]

RSC Adv
Hou X, Huang M, Zhang Q, Yao Q, Yang J.
europepmc   +1 more source

Restoring well-being: quality of life improvements following dolutegravir-based therapy after antiretroviral failure. [PDF]

Braz J Infect Dis
Lins-Kusterer L, Brites C, de Lacerda MVG, Page K, Bahia F, Luz E, Ramalho A, Wagner S, Arriaga MB, CODE research group collaborators.   +9 more
europepmc   +1 more source